Related Experiment Videos
beta 2-Microglobulin and the kidney: an overview
1University of Alabama at Birmingham 35233-1924.
Ultrastructural Pathology
|January 1, 1994
Abstract:
beta 2 microglobulin is a potentially amyloidogenic low molecular weight protein. Increased serum levels are seen in renal diseases that decrease glomerular filtration and/or tubular reabsorption, dialysis patients, chronic inflammatory diseases, and certain malignancies. Various aspects of beta 2 microglobulin metabolism and its accumulation in the kidney are addressed.
Insights
Beta 2 microglobulin, a protein, can form amyloid deposits. Elevated levels indicate kidney dysfunction, dialysis complications, inflammation, or cancer, highlighting its role in disease.
Area of Science:
- Biochemistry
- Nephrology
- Immunology
Background:
- Beta 2 microglobulin (B2M) is a low molecular weight protein.
- B2M is potentially amyloidogenic, meaning it can form abnormal protein deposits.
- Elevated serum B2M levels are associated with various clinical conditions.
Purpose of the Study:
- To review the metabolism of beta 2 microglobulin.
- To discuss the accumulation of beta 2 microglobulin in the kidney.
- To correlate B2M levels with specific disease states.
Main Methods:
- Literature review of studies on beta 2 microglobulin.
- Analysis of factors affecting B2M serum levels.
- Examination of renal handling of B2M.
Main Results:
- Increased serum B2M is observed in renal diseases impairing filtration or reabsorption.
- Dialysis patients frequently exhibit higher B2M levels.
- Chronic inflammatory diseases and certain cancers are linked to elevated B2M.
Conclusions:
- Beta 2 microglobulin serves as a biomarker for kidney function.
- Abnormal B2M metabolism and accumulation are implicated in renal pathology.
- Monitoring B2M levels is crucial in managing patients with kidney disease, on dialysis, or with inflammatory conditions and malignancies.